Molecularly imprinted cryogel membranes for mitomycin C delivery

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Polymer Chemistry

Background:

• Developing effective drug delivery systems is crucial for targeted cancer therapy.
• Molecularly imprinted polymers (MIPs) offer high specificity for drug binding and release.
• Cryogel technology enables the creation of macroporous scaffolds for biomedical applications.

Purpose of the Study:

• To design and characterize implantable molecularly imprinted cryogel membranes for controlled delivery of Mitomycin C.
• To investigate the influence of cross-linker ratio and template concentration on drug release kinetics.
• To evaluate the hemocompatibility of the developed cryogel systems.

Main Methods:

• Synthesis of poly(2-hydroxyethyl methacrylate-N-methacryloyl-l-glutamic acid) cryogel membranes via free-radical bulk polymerization under partially frozen conditions.
• Characterization using swelling tests, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and surface area analysis.
• In vitro drug release studies and hemocompatibility testing.

Main Results:

• The Mitomycin C imprinted cryogel membranes exhibited a macroporous structure (10-100 μm diameter).
• Cumulative drug release decreased with higher cross-linker ratios and increased with higher template content.
• In vitro hemocompatibility tests indicated suitability for implantation.
• The drug release mechanism followed non-Fickian transport.

Conclusions:

• Molecularly imprinted cryogel membranes are a promising platform for implantable drug delivery of antineoplastic agents like Mitomycin C.
• Controlling cryogel composition (cross-linker and template content) allows modulation of drug release rates.
• The developed system demonstrates potential for localized and sustained cancer treatment.